Cervical Cancer


Latest News

Cervical Cancer
Cadonilimab/Chemotherapy Meets Primary End Point in Phase 3 AK104-303 Trial

December 3rd 2023

Frontline cadonilimab (AK104) and platinum-based chemotherapy improved progression-free survival in patients with recurrent or metastatic cervical cancer.

cervical cancer
Atezolizumab Combo Reduces Risk of Death by 32% Over Bevacizumab/Chemo in Recurrent Cervical Cancer

November 9th 2023

gynecologic cancer
Tisotumab Vedotin Reduces Risk of Death by 30% in Recurrent/Metastatic Cervical Cancer

October 24th 2023

cervical cancer
Induction Chemotherapy Improves Chemoradiation Success in Locally Advanced Cervical Cancer

October 23rd 2023

Mammogram © Tyler Olson - stockadobe.com
Opinion: Cancer Screenings, Although Not Perfect, Remain Valuable

October 18th 2023

More News

© 2023 MJH Life Sciences

All rights reserved.